Biotech - Spark Newswire

2 minute read

Arrowhead Highlights Presentation Of Preclinical Data On ARO-DUX4 At FSHD Society International Research Congress

Today, 1:00 PM

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today presented preclinical data on the development of ARO-DUX4, the company's investigational RNA interference (RNAi) therapeutic being developed as a treatment for

ARWR

1 minute read

BioMarin Receives Positive CHMP Opinion In Europe For Vosoritide For Treatment Of Children With Achondroplasia From Age 2 Until Growth Plates Close

By Bill Haddad

Today, 1:00 PM

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization for vosoritide, a once daily

BMRN

4 minute read

Regulus Therapeutics To Present Additional Data From Autosomal Dominant Polycystic Kidney Disease Program At PKD Connect 2021 At 2-3 p.m. CDT.

By Bill Haddad

Today, 1:00 PM

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today

RGLS

1 minute read

Pfizer Inc Says Believe Benefits Of Chantix/Champix Outweigh The Very Low Potential Risks, If Any

By Bill Haddad

Today, 1:00 PM

-Reuters

PFE

3 minute read

Terns Announces Initiation Of Patient Dosing In AVIATION Phase 1b NASH Clinical Trial Of VAP-1 Inhibitor TERN-201

By Bill Haddad

Today, 1:00 PM

TERN-201 is a highly selective VAP-1 inhibitor intended to address chronic liver inflammation and fibrosis in NASH Sustained VAP-1 inhibition with TERN-201 may make it suitable for co-administration with other

TERN

5 minute read

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End

By Rachael Green

Today, 1:00 PM

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

ARTL

2 minute read

electroCore Highlights Publication Of Study On Effect Of Non-Invasive Vagus Nerve Stimulation In Cognitive Performance Caused By Sleep Deprivation

By Bill Haddad

Today, 1:00 PM

lectroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on June 10, 2021, entitled "Effects of Transcutaneous Vagal Nerve

ECOR

5 minute read

The Daily Biotech Pulse: Lilly Spikes On Alzheimer’s Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO

By Shanthi Rexaline

Today, 1:00 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23)

ABCL

4 minute read

Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors

By Spruce Biosciences

Today, 1:00 PM

Dr. Ways’ Expertise in Late-Stage Clinical Development in Therapeutics Areas of High Unmet Medical Meet Supports Spruce’s Goal to Expand Portfolio of Indications for Tildacerfont

SPRB

2 minute read

Bio-Techne And Catamaran Bio Announce Expansion Of Collaboration For CAR-NK Cell Manufacturing Technologies To Include Development Of ‘novel cell expansion technologies for use in the manufacturing of CAR-NK cell therapy products’

By Bill Haddad

Today, 1:00 PM

Bio-Techne Corporation (NASDAQ:TECH) and Catamaran Bio today announced an expansion of their collaboration for the development of cell engineering and cell process technologies for use by Catamaran in the manufacturing

TECH